Cargando…
The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease that predominantly affects children. However, it can persist in adulthood and/or start at older ages. Both dysfunction of the epidermal barrier and immune dysregulation are known to play a role in the pathogenesis of AD. In the...
Autores principales: | Napolitano, Maddalena, Fabbrocini, Gabriella, Ruggiero, Angelo, Marino, Vincenzo, Nocerino, Mariateresa, Patruno, Cataldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956861/ https://www.ncbi.nlm.nih.gov/pubmed/33731985 http://dx.doi.org/10.2147/DDDT.S240866 |
Ejemplares similares
-
Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review
por: Napolitano, Maddalena, et al.
Publicado: (2022) -
The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023) -
COVID-19, quarantine, and atopic dermatitis
por: Patruno, Cataldo, et al.
Publicado: (2020) -
Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018) -
Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
por: Cantelli, Mariateresa, et al.
Publicado: (2022)